Arrowhead Research | Passività Correnti



Current Liabilities Cambiamento Data
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Incyte USD 1.64B 140.2M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
Merck USD 28.42B 1.17B 2024-12
Moderna USD 2.21B 5M 2024-12
Novartis USD 28.69B 560M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Xencor USD 87.43M 4.54M 2024-12



Arrowhead Research Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.